Gregor Ortmayr (GO) completed his studies in human medicine at the Medical University of Vienna in 2020. He subsequently accomplished his basic clinical traineeship at the Department of Clinical Oncology from the General Hospital of Vienna. Before starting his full-time medical residency at the Department of Internal Medicine I/Oncology he desired to obtain scientific qualifications as a physician scientist. GO applied for the highly competitive “International PhD Program in Translational Oncology” (IPPTO) at the Medical University Vienna and was accepted. Since April 2021, he has focused as a PhD student on the IPPTO program in the research team of Prof. Mikulits at the Institute for Cancer Research on extracellular vesicle (EV)-mediated long-range signaling and premetastatic niche formation in the field of hepatocellular carcinoma.
Gregor Ortmayr (GO) completed his studies in human medicine at the Medical University of Vienna in 2020. He subsequently accomplished his basic clinical traineeship at the Department of Clinical Oncology from the General Hospital of Vienna. Before starting his full-time medical residency at the Department of Internal Medicine I/Oncology he desired to obtain scientific qualifications as a physician scientist. GO applied for the highly competitive “International PhD Program in Translational Oncology” (IPPTO) at the Medical University Vienna and was accepted. Since April 2021, he has focused as a PhD student on the IPPTO program in the research team of Prof. Mikulits at the Institute for Cancer Research on extracellular vesicle (EV)-mediated long-range signaling and premetastatic niche formation in the field of hepatocellular carcinoma.